Showing 66,061 - 66,080 results of 101,291 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.35s Refine Results
  1. 66061

    Effect of 10 μM 8-cyclopentyltheophylline (8-CPT) on evoked EPSP depression produced by <i>in vitro</i> ischemia. by Shirin Jalini (2551054)

    Published 2016
    “…<p>Some OGD-induced decrease in fEPSP persists in the presence of an A<sub>1</sub>-antagonist. 8-CPT reduced the OGD-induced percentage change in fEPSPs relative to control after 2 min (n = 5, <i>p</i><0.0003) and 4 min (n = 5, <i>p</i><0.005), but not after 6 min (n = 6, <i>p</i>>0.14) of OGD. * p < 0.05, Student t-test</p>…”
  2. 66062

    Responsiveness of WT and transgenic mice to two stage carcinogenesis protocol (DMBA/TPA). by Jian Fu (41067)

    Published 2010
    “…(B) SCC/papilloma ratio indicating a sharp decrease in K5-VILIP-1 with respect to WT mice (p<0.01). …”
  3. 66063

    Analysis of bone marrow B cell development in Gfi1<sup>−/−</sup> mice. by Chozhavendan Rathinam (273627)

    Published 2007
    “…Flow cytometry was done in pooled cell suspensions (n = 5 mice). Shown is a representative experiment of 5.…”
  4. 66064

    WFA inhibits STS cell growth. by Guy Lahat (250220)

    Published 2010
    “…<p><i>A)</i> WFA treatment (1 µM/24 h) results in marked morphological changes, including cell-rounding and nuclear condensation, in STS cells; <i>B)</i> MTS assays demonstrate a WFA-induced, dose-dependent decrease in STS cell growth; <i>C)</i> WFA (0.5 µM/24 h) markedly inhibits STS cell colony formation capacity measured after ten days; <i>D)</i> WFA (0.5 µM/24 h) abrogates STS cell anchorage independent growth measured after three weeks. …”
  5. 66065

    Immmocytochemistry of DMT1−IRE, DMT1+IRE, Fpn1 and TfR1 proteins in cortical neurons. by Fang Du (232423)

    Published 2013
    “…<p>Cells were treated with L-DOPA (0, 1, 5, 10, 100, 200 µM) in DMEM+5%FBS for 16 hours and then immunostained for DMT1−IRE (A), DMT1+IRE (B), Fpn1 (C) or TfR1 (D) antibodies. …”
  6. 66066

    Intravenous self-administration of cocaine is not altered by bilateral PPTg cholinergic cell loss. by Stephan Steidl (339615)

    Published 2014
    “…All rats showed a decrease in cocaine intake on the first post-lesion testing day that returned to pre-lesion baseline levels by the third post-lesion testing day. …”
  7. 66067

    Table 1_Effects of two different variants in the MAGT1 gene on B cell subsets, platelet function, and cell glycome composition.pdf by Lucía del Pino Molina (15407477)

    Published 2025
    “…</p>Methods<p>We performed a functional validation of these two variants in the MAGT1 gene and their association with decreased NKG2D expression, uncontrolled EBV viremia, and the development of lymphoma-associated complications in three members of the same family.…”
  8. 66068

    Image_8_Breathing Abnormalities During Sleep and Wakefulness in Rett Syndrome: Clinical Relevance and Paradoxical Relationship With Circulating Pro-oxidant Markers.pdf by Silvia Leoncini (383432)

    Published 2022
    “…</p>Methods<p>Female patients with a clinical diagnosis of typical RTT (n = 66), MECP2 gene mutation, and apneas were enrolled (mean age: 12.5 years). …”
  9. 66069

    Image_7_Breathing Abnormalities During Sleep and Wakefulness in Rett Syndrome: Clinical Relevance and Paradoxical Relationship With Circulating Pro-oxidant Markers.pdf by Silvia Leoncini (383432)

    Published 2022
    “…</p>Methods<p>Female patients with a clinical diagnosis of typical RTT (n = 66), MECP2 gene mutation, and apneas were enrolled (mean age: 12.5 years). …”
  10. 66070

    Image_9_Breathing Abnormalities During Sleep and Wakefulness in Rett Syndrome: Clinical Relevance and Paradoxical Relationship With Circulating Pro-oxidant Markers.pdf by Silvia Leoncini (383432)

    Published 2022
    “…</p>Methods<p>Female patients with a clinical diagnosis of typical RTT (n = 66), MECP2 gene mutation, and apneas were enrolled (mean age: 12.5 years). …”
  11. 66071

    Image_3_Breathing Abnormalities During Sleep and Wakefulness in Rett Syndrome: Clinical Relevance and Paradoxical Relationship With Circulating Pro-oxidant Markers.pdf by Silvia Leoncini (383432)

    Published 2022
    “…</p>Methods<p>Female patients with a clinical diagnosis of typical RTT (n = 66), MECP2 gene mutation, and apneas were enrolled (mean age: 12.5 years). …”
  12. 66072

    Image_2_Breathing Abnormalities During Sleep and Wakefulness in Rett Syndrome: Clinical Relevance and Paradoxical Relationship With Circulating Pro-oxidant Markers.pdf by Silvia Leoncini (383432)

    Published 2022
    “…</p>Methods<p>Female patients with a clinical diagnosis of typical RTT (n = 66), MECP2 gene mutation, and apneas were enrolled (mean age: 12.5 years). …”
  13. 66073

    Image_10_Breathing Abnormalities During Sleep and Wakefulness in Rett Syndrome: Clinical Relevance and Paradoxical Relationship With Circulating Pro-oxidant Markers.pdf by Silvia Leoncini (383432)

    Published 2022
    “…</p>Methods<p>Female patients with a clinical diagnosis of typical RTT (n = 66), MECP2 gene mutation, and apneas were enrolled (mean age: 12.5 years). …”
  14. 66074

    Image_1_Breathing Abnormalities During Sleep and Wakefulness in Rett Syndrome: Clinical Relevance and Paradoxical Relationship With Circulating Pro-oxidant Markers.pdf by Silvia Leoncini (383432)

    Published 2022
    “…</p>Methods<p>Female patients with a clinical diagnosis of typical RTT (n = 66), MECP2 gene mutation, and apneas were enrolled (mean age: 12.5 years). …”
  15. 66075

    Image_4_Breathing Abnormalities During Sleep and Wakefulness in Rett Syndrome: Clinical Relevance and Paradoxical Relationship With Circulating Pro-oxidant Markers.pdf by Silvia Leoncini (383432)

    Published 2022
    “…</p>Methods<p>Female patients with a clinical diagnosis of typical RTT (n = 66), MECP2 gene mutation, and apneas were enrolled (mean age: 12.5 years). …”
  16. 66076

    Image_6_Breathing Abnormalities During Sleep and Wakefulness in Rett Syndrome: Clinical Relevance and Paradoxical Relationship With Circulating Pro-oxidant Markers.pdf by Silvia Leoncini (383432)

    Published 2022
    “…</p>Methods<p>Female patients with a clinical diagnosis of typical RTT (n = 66), MECP2 gene mutation, and apneas were enrolled (mean age: 12.5 years). …”
  17. 66077

    Computed Tomography Measurement of Rib Cage Morphometry in Emphysema by Nicola Sverzellati (440066)

    Published 2013
    “…Lower rib cage areas decreased as FVC% decreased (5.1 cm<sup>2</sup>; 95% CI: 2.5 to 7.6 for 10 percentage points of FVC variation).…”
  18. 66078

    Data_Sheet_1_Study on Optimal Parameter and Target for Pulsed-Field Ablation of Atrial Fibrillation.DOCX by Xuying Ye (11459722)

    Published 2021
    “…Expressed Cx45 proteins were increased in H9C2 but decreased in A7r5 cells. Bidirectional PFA performed on Bama minipigs was able to effectively block electrical activity from the pulmonary vein to the atrium with week muscle contraction, not generating pulmonary vein stenosis. …”
  19. 66079

    Video_2_Study on Optimal Parameter and Target for Pulsed-Field Ablation of Atrial Fibrillation.MP4 by Xuying Ye (11459722)

    Published 2021
    “…Expressed Cx45 proteins were increased in H9C2 but decreased in A7r5 cells. Bidirectional PFA performed on Bama minipigs was able to effectively block electrical activity from the pulmonary vein to the atrium with week muscle contraction, not generating pulmonary vein stenosis. …”
  20. 66080

    Video_1_Study on Optimal Parameter and Target for Pulsed-Field Ablation of Atrial Fibrillation.MP4 by Xuying Ye (11459722)

    Published 2021
    “…Expressed Cx45 proteins were increased in H9C2 but decreased in A7r5 cells. Bidirectional PFA performed on Bama minipigs was able to effectively block electrical activity from the pulmonary vein to the atrium with week muscle contraction, not generating pulmonary vein stenosis. …”